Tirbanibulin for Topical AK Treatment
Dr. George Martin discusses recently FDA-approved tirbanibulin 1% topical ointment for treating actinic keratosis. Tirbanibulin (Klysyri) ointment 1% (Almirall; Barcelona, Spain) is being called a game changer for the treatment of actinic keratosis (AK). FDA-approved in December 2020, tirbanibulin is a short-duration topical used once daily for five days. In an exclusive interview with The […]